Continuous Manufacturing of Pharmaceuticals: Scale-up of a Hot Melt Extrusion Process

Installation was performed during the summer of 2024, and the system has already successfully completed its first production run for a leading biotech company.

This episode is a compilation of comments taken from a series of interviews where experts reveal the trends that have impacted the bio/pharma industry in 2024 and those they expect to be impactful in 2025.

Increasing API and formulation complexity and new delivery strategies are driving innovations in taste-masking.

This episode is a compilation of comments taken from a series of interviews where experts are discussing how AI might impact the global bio/pharma industry in the future.

Rapid market growth in biologics is helping the packaging market expand as well, but the complex nature of biologics and the desire for personalized therapies present unique hurdles to make packaging solutions cost-effective and safe for patients.

Process consistency and robustness, analytical excellence, and regulatory compliance are essential in the scale-up of biosimilars.